End Pause of J&J Vaccine, But Add Warning
April 23, 2021 – Use of the Johnson & Johnson COVID-19 vaccine is set to resume in the United States for all adults, a CDC advisory committee voted on Friday afternoon.
The vote was 10 votes to 4 with one abstention. The decisions also include instructions for a warning to be included with vaccine vials. It is for women under 50 who are at increased risk of a rare but serious blood clot disorder called thrombosis with thrombocytopenia syndrome (TTS).
As of April 21, 15 cases of TTS, all in women and 13 of them in women under the age of 50, have been confirmed among 7.98 million doses of the J&J vaccine administered in the United States. Three women died.
The FDA and CDC recommended the break on April 13 after reporting that 6 women developed a rare blood clotting disorder 6 to 13 days after receiving the J&J vaccine.
This story will be updated.
Our sincere thanks to